Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Dogecoin Cash
AddedFeb 19, 2024
UpdatedJul 9, 2026
Dogecoin Cash

Dogecoin Cash

Public

Cannabis-focused pharmaceutical firm, licensing IP, and driving marketing for cannabis products.

HQ
Mesquite, NV, US
Founded
2005
Overview
Compare
Employees
Website

Cannabis Sativa Inc., founded with a mission to brand and market high-quality, legal cannabis and hemp products, focuses on innovation within the telehealth sector and certified manufacturing of hemp CBD products. The company offers a range of services and products to both consumers and businesses, emphasizing its role as a first mover in telehealth. Cannabis Sativa Inc. is publicly traded under the ticker OTCQB:CBDS.

Notable affiliated individuals include key innovators and leaders in the cannabis industry, though specific names are not provided. The company has achieved significant milestones in telehealth and CBD product certification, contributing to the broader acceptance and integration of cannabis-related products in mainstream markets. Its impact is seen in advancing the legal cannabis industry through strategic branding, marketing, and intellectual property licensing.

Dogecoin Cash - Similar Companies

Cannabis Strategic Ventures logo

Cannabis Strategic Ventures

Grassp Health logo

Grassp Health

Medical Marijuana logo

Medical Marijuana

Tilray logo

Tilray

tilraymedical.ca

Marijuana Company of America logo

Marijuana Company of America

THC Farmaceuticals logo

THC Farmaceuticals

toke.city

Clear Cannabis logo

Clear Cannabis

Cannabis Kinetics logo

Cannabis Kinetics

American Cannabis Company logo

American Cannabis Company

PharmaCann logo

PharmaCann

pharmacann.com

The Cannabist Company logo

The Cannabist Company

columbia.care

MedMen logo

MedMen

CannaVest logo

CannaVest

AmeriCann logo

AmeriCann

americann.co

Pure Spectrum CBD logo

Pure Spectrum CBD

Dogecoin Cash - Quick Facts

Who are Dogecoin Cash's competitors?

Companies similar to Dogecoin Cash include Cannabis Strategic Ventures, Grassp Health, Medical Marijuana and Tilray.

When was Dogecoin Cash founded?

Dogecoin Cash was founded in 2005.

Where is Dogecoin Cash's headquarters located?

Dogecoin Cash's headquarters is located in Mesquite, NV, US.

How many employees does Dogecoin Cash have?

Dogecoin Cash has 14 employees as of Feb 6, 2024.

Dogecoin Cash - Classification

Industry
  • Retail
Ownership
  • Public
Technology
  • Telemedicine
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
  • Transactional
Customer
  • Consumers
Main Product
  • CBD Products
  • Telehealth
Tags
  • Businesses
  • Healthtech
Unique IDs
  • secCik: 0001360442
  • ticker: DOGP
NAICS
  • 459900Other Miscellaneous Retailers
  • 459990All Other Miscellaneous Retailers
  • 459991Tobacco, Electronic Cigarette, and Other Smoking Supplies Retailers
  • 450000Retail Trade
  • 459000Sporting Goods, Hobby, Musical Instrument, Book, and Miscellaneous Retailers
SIC
  • 7200Personal Services
Show 5 more industry codes
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 6000Depository Institutions
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified